Literature DB >> 10923984

Functional anatomy of movement disorders.

A R Crossman1.   

Abstract

Models of basal ganglia function are described which encapsulate the principal pathophysiological mechanisms underlying parkinsonian akinesia on the one hand and abnormal involuntary movement disorders (dyskinesias) on the other. In Parkinson's disease, degeneration of the nigrostriatal dopamine system leads to overactivity of the 'indirect' striatopallidal projection to the lateral (external) segment of the globus pallidus. This causes inhibition of lateral pallidal neurons, which in turn project to the subthalamic nucleus. Disinhibition of the subthalamic nucleus leads to abnormal subthalamic overactivity and, as a consequence, overactivity of medial (internal) pallidal output neurons. Dyskinesias, such as are observed in Huntington's disease, levodopa-induced dyskinesia and ballism, share mechanistic features in common and are associated with decreased neuronal activity in both the subthalamic nucleus and the medial globus pallidus.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10923984      PMCID: PMC1468094          DOI: 10.1046/j.1469-7580.2000.19640519.x

Source DB:  PubMed          Journal:  J Anat        ISSN: 0021-8782            Impact factor:   2.610


  48 in total

Review 1.  Basal ganglia-thalamocortical circuits: parallel substrates for motor, oculomotor, "prefrontal" and "limbic" functions.

Authors:  G E Alexander; M D Crutcher; M R DeLong
Journal:  Prog Brain Res       Date:  1990       Impact factor: 2.453

2.  Common neural mechanisms in experimental chorea and hemiballismus in the monkey. Evidence from 2-deoxyglucose autoradiography.

Authors:  I J Mitchell; A Jackson; M A Sambrook; A R Crossman
Journal:  Brain Res       Date:  1985-07-29       Impact factor: 3.252

3.  Lesion of the subthalamic nucleus for the alleviation of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-induced parkinsonism in the primate.

Authors:  T Z Aziz; D Peggs; M A Sambrook; A R Crossman
Journal:  Mov Disord       Date:  1991       Impact factor: 10.338

4.  Continuous administration decreases and pulsatile administration increases behavioral sensitivity to a novel dopamine D2 agonist (U-91356A) in MPTP-exposed monkeys.

Authors:  P J Blanchet; F Calon; J C Martel; P J Bédard; T Di Paolo; R R Walters; M F Piercey
Journal:  J Pharmacol Exp Ther       Date:  1995-02       Impact factor: 4.030

5.  Reversal of rigidity and improvement in motor performance by subthalamic high-frequency stimulation in MPTP-treated monkeys.

Authors:  A Benazzouz; C Gross; J Féger; T Boraud; B Bioulac
Journal:  Eur J Neurosci       Date:  1993-04-01       Impact factor: 3.386

6.  Subthalamic nucleotomy alleviates parkinsonism in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-exposed primate.

Authors:  T Z Aziz; D Peggs; E Agarwal; M A Sambrook; A R Crossman
Journal:  Br J Neurosurg       Date:  1992       Impact factor: 1.596

7.  Intracellular study of rat globus pallidus neurons: membrane properties and responses to neostriatal, subthalamic and nigral stimulation.

Authors:  H Kita; S T Kitai
Journal:  Brain Res       Date:  1991-11-15       Impact factor: 3.252

8.  Acute and long-term effects of subthalamic nucleus stimulation in Parkinson's disease.

Authors:  A L Benabid; P Pollak; C Gross; D Hoffmann; A Benazzouz; D M Gao; A Laurent; M Gentil; J Perret
Journal:  Stereotact Funct Neurosurg       Date:  1994       Impact factor: 1.875

9.  Ventroposterolateral pallidotomy.

Authors:  L V Laitinen
Journal:  Stereotact Funct Neurosurg       Date:  1994       Impact factor: 1.875

10.  Preproenkephalin messenger RNA-containing neurons in striatum of patients with symptomatic and presymptomatic Huntington's disease: an in situ hybridization study.

Authors:  R L Albin; Y Qin; A B Young; J B Penney; M F Chesselet
Journal:  Ann Neurol       Date:  1991-10       Impact factor: 10.422

View more
  21 in total

1.  Differential electrophysiological changes in striatal output neurons in Huntington's disease.

Authors:  Véronique M André; Carlos Cepeda; Yvette E Fisher; My Huynh; Nora Bardakjian; Sumedha Singh; X William Yang; Michael S Levine
Journal:  J Neurosci       Date:  2011-01-26       Impact factor: 6.167

2.  Changing views of basal ganglia circuits and circuit disorders.

Authors:  Mahlon DeLong; Thomas Wichmann
Journal:  Clin EEG Neurosci       Date:  2010-04       Impact factor: 1.843

Review 3.  Mechanisms underlying the onset and expression of levodopa-induced dyskinesia and their pharmacological manipulation.

Authors:  Mahmoud M Iravani; Peter Jenner
Journal:  J Neural Transm (Vienna)       Date:  2011-09-01       Impact factor: 3.575

4.  HCN channels modulate the activity of the subthalamic nucleus in vivo.

Authors:  Wen-Shuai Deng; Yun-Xia Jiang; Xiao-Hua Han; Yan Xue; Hua Wang; Peng Sun; Lei Chen
Journal:  J Mol Neurosci       Date:  2014-05-21       Impact factor: 3.444

5.  Immunology, autoimmunity, and autoantibodies in Parkinson's disease.

Authors:  Michal Benkler; Nancy Agmon-Levin; Sharon Hassin-Baer; Oren S Cohen; Oscar-Danilo Ortega-Hernandez; Amalia Levy; Samuel-Datum Moscavitch; Martine Szyper-Kravitz; Maya Damianovich; Miri Blank; Joab Chapman; Yehuda Shoenfeld
Journal:  Clin Rev Allergy Immunol       Date:  2012-04       Impact factor: 8.667

6.  Environmental toxicant effects on neuroendocrine function.

Authors:  A C Gore
Journal:  Endocrine       Date:  2001-03       Impact factor: 3.633

Review 7.  Dopamine and glutamate in Huntington's disease: A balancing act.

Authors:  Véronique M André; Carlos Cepeda; Michael S Levine
Journal:  CNS Neurosci Ther       Date:  2010-04-08       Impact factor: 5.243

Review 8.  Therapy development in Huntington disease: From current strategies to emerging opportunities.

Authors:  Audrey S Dickey; Albert R La Spada
Journal:  Am J Med Genet A       Date:  2017-12-08       Impact factor: 2.802

Review 9.  Update on models of basal ganglia function and dysfunction.

Authors:  Mahlon DeLong; Thomas Wichmann
Journal:  Parkinsonism Relat Disord       Date:  2009-12       Impact factor: 4.891

10.  Short-term depression of external globus pallidus-subthalamic nucleus synaptic transmission and implications for patterning subthalamic activity.

Authors:  Jeremy F Atherton; Ariane Menard; Nadia Urbain; Mark D Bevan
Journal:  J Neurosci       Date:  2013-04-24       Impact factor: 6.167

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.